Abstract
Individuals harboring germ-line DICER1 mutations are predisposed to a rare cancer syndrome, the DICER1 Syndrome or pleuropulmonary blastoma-familial tumor and dysplasia syndrome [online Mendelian inheritance in man (OMIM) #601200]. In addition, specific somatic mutations in the DICER1 RNase III catalytic domain have been identified in several DICER1-associated tumor types. Pituitary blastoma (PitB) was identified as a distinct entity in 2008, and is a very rare, potentially lethal early childhood tumor of the pituitary gland. Since the discovery by our team of an inherited mutation in DICER1 in a child with PitB in 2011, we have identified 12 additional PitB cases. We aimed to determine the contribution of germ-line and somatic DICER1 mutations to PitB. We hypothesized that PitB is a pathognomonic feature of a germ-line DICER1 mutation and that each PitB will harbor a second somatic mutation in DICER1. Lymphocyte or saliva DNA samples ascertained from ten infants with PitB were screened and nine were found to harbor a heterozygous germ-line DICER1 mutation. We identified additional DICER1 mutations in nine of ten tested PitB tumor samples, eight of which were confirmed to be somatic in origin. Seven of these mutations occurred within the RNase IIIb catalytic domain, a domain essential to the generation of 5p miRNAs from the 5′ arm of miRNA-precursors. Germ-line DICER1 mutations are a major contributor to PitB. Second somatic DICER1 “hits” occurring within the RNase IIIb domain also appear to be critical in PitB pathogenesis.
Similar content being viewed by others
References
Anglesio MS, Wang Y, Yang W, Senz J, Wan A, Heravi-Moussavi A, Salamanca C, Maines-Bandiera S, Huntsman DG, Morin GB (2013) Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J Pathol 229(3):400–409. doi:10.1002/path.4135
Bahubeshi A, Bal N, Rio Frio T, Hamel N, Pouchet C, Yilmaz A, Bouron-Dal Soglio D, Williams GM, Tischkowitz M, Priest JR, Foulkes WD (2010) Germline DICER1 mutations and familial cystic nephroma. J Med Genet 47(12):863–866. doi:10.1136/jmg.2010.081216
Baker M (2012) Cancer stem cells tracked. Nature 488(7409):13–14. doi:10.1038/488013a
Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488(7412):522–526. doi:10.1038/nature11287
Foulkes WD, Bahubeshi A, Hamel N, Pasini B, Asioli S, Baynam G, Choong CS, Charles A, Frieder RP, Dishop MK, Graf N, Ekim M, Bouron-Dal Soglio D, Arseneau J, Young RH, Sabbaghian N, Srivastava A, Tischkowitz MD, Priest JR (2011) Extending the phenotypes associated with DICER1 mutations. Hum Mutat 32(12):1381–1384. doi:10.1002/humu.21600
Gurtan AM, Lu V, Bhutkar A, Sharp PA (2012) In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA 18(6):1116–1122. doi:10.1261/rna.032680.112
Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, Williams G, Bracamontes D, Messinger Y, Goodfellow PJ (2009) DICER1 mutations in familial pleuropulmonary blastoma. Science 325(5943):965. doi:10.1126/science.1174334
Horvath E, Vidal S, Syro LV, Kovacs K, Smyth HS, Uribe H (2001) Severe lymphocytic adenohypophysitis with selective disappearance of prolactin cells: a histologic, ultrastructural and immunoelectron microscopic study. Acta Neuropathol 101(6):631–637
Klein S, Lee H, Ghahremani S et al (2014) Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome. J Med Genet 51:294–302
Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS (1989) Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134(2):345–353
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610. doi:10.1038/nrg2843
Levy SR, Wynne CV Jr, Lorentz WB Jr (1982) Cushing’s syndrome in infancy secondary to pituitary adenoma. Am J Dis Child 136(7):605–607
List JV, Sobottka S, Huebner A, Bonk C, Koy J, Pinzer T, Schackert G (1999) Cushing’s disease in a 7-month-old girl due to a tumor producing adrenocorticotropic hormone and thyreotropin-secreting hormone. Pediatr Neurosurg 31(1):7–11.
Maeder P, Gudinchet F, Rillet B, Theintz G, Meuli R (1996) Cushing’s disease due to a giant pituitary adenoma in early infancy: CT and MRI features. Pediatr Radiol 26(1):48–50
Miller WL, Townsend JJ, Grumbach MM, Kaplan SL (1979) An infant with Cushing’s disease due to an adrenocorticotropin-producing pituitary adenoma. J Clin Endocrinol Metab 48(6):1017–1025. doi:10.1210/jcem-48-6-1017
Min HS, Lee SJ, Kim SK, Park SH (2007) Pituitary adenoma with rich folliculo-stellate cells and mucin-producing epithelia arising in a 2-year-old girl. Pathol Int 57(9):600–605. doi:10.1111/j.1440-1827.2007.02145.x
Moriarty M, Hoe F (2009) Cushing disease in a toddler: not all obese children are just fat. Curr Opin Pediatr 21(4):548–552. doi:10.1097/MOP.0b013e32832d1f4f
Murray MJ, Bailey S, Raby KL, Saini HK, de Kock L, Burke GA, Foulkes WD, Enright AJ, Coleman N, Tischkowitz M (2014) Serum levels of mature microRNAs in DICER1-mutated pleuropulmonary blastoma. Oncogenesis 3:e87. doi:10.1038/oncsis.2014.1
Peng C, Li N, Ng YK, Zhang J, Meier F, Theis FJ, Merkenschlager M, Chen W, Wurst W, Prakash N (2012) A unilateral negative feedback loop between miR-200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation. J Neurosci 32(38):13292–13308. doi:10.1523/JNEUROSCI.2124-12.2012
Pullins DI, Challa VR, Marshall RB, Davis CH Jr (1984) ACTH-producing pituitary adenoma in an infant with cysts of the kidneys and lungs. Histopathology 8(1):157–163
Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD (2012) Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49(7):417–419. doi:10.1136/jmedgenet-2012-100898
Sabbaghian N, Srivastava A, Hamel N, Plourde F, Gajtko-Metera M, Niedziela M, Foulkes WD (2013) Germ-line deletion in DICER1 revealed by a novel MLPA assay using synthetic oligonucleotides. Eur J Hum Genet. doi:10.1038/ejhg.2013.215
Scheithauer BW, Horvath E, Abel TW, Robital Y, Park SH, Osamura RY, Deal C, Lloyd RV, Kovacs K (2012) Pituitary blastoma: a unique embryonal tumor. Pituitary 15(3):365–373. doi:10.1007/s11102-011-0328-x
Scheithauer BW, Kovacs K, Horvath E, Kim DS, Osamura RY, Ketterling RP, Lloyd RV, Kim OL (2008) Pituitary blastoma. Acta Neuropathol 116(6):657–666. doi:10.1007/s00401-008-0388-9
Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, Barfoot R, Burke A, Chisholm J, Hewitt M, Jenkinson H, King D, Morland B, Pizer B, Prescott K, Saggar A, Side L, Traunecker H, Vaidya S, Ward P, Futreal PA, Vujanic G, Nicholson AG, Sebire N, Turnbull C, Priest JR, Pritchard-Jones K, Houlston R, Stiller C, Stratton MR, Douglas J, Rahman N (2011) DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 48(4):273–278. doi:10.1136/jmg.2010.083790
Sumner TE, Volberg FM (1982) Cushing’s syndrome in infancy due to pituitary adenoma. Pediatr Radiol 12(2):81–83
Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104(16):6788–6793. doi:10.1073/pnas.0701724104
Wildi-Runge S, Bahubeshi A, Carret A-S, Crevier L, Robitaille Y, Kovacs K, Horvath E, Scheithauer BW, Foulkes WD, Deal C (2011) New phenotype in the familial DICER1 tumor syndrome: pituitary blastoma presenting at age 9 months. endocrine reviews 32(03_MeetingAbstracts):P1–P777
Witkowski L, Mattina J, Schonberger S, Murray MJ, Choong CS, Huntsman DG, Reis-Filho JS, McCluggage WG, Nicholson JC, Coleman N, Calaminus G, Schneider DT, Arseneau J, Stewart CJ, Foulkes WD (2013) DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer 109(10):2744–2750. doi:10.1038/bjc.2013.637
Wu MK, Sabbaghian N, Xu B, Addidou-Kalucki S, Bernard C, Zou D, Reeve AE, Eccles MR, Cole C, Choong CS, Charles A, Tan TY, Iglesias DM, Goodyer PR, Foulkes WD (2013) Biallelic DICER1 mutations occur in Wilms tumours. J Pathol 230(2):154–164. doi:10.1002/path.4196
Acknowledgements
We thank the families involved in this research for their consent to participation and all the clinicians for referring cases and providing samples. We thank Dr. Benoît Lhermitte, Dr. Alistair Lammie, Dr. Cynthia Andoniadou, Dr. Helen Spoudeas, Dr. Oh-Lyong Kim, Dr. Andrew Peet, Dr. Angela Hübner, Dr. Walter Miller, Claudia Retamal-Muñoz, Dr. Bénédict Rilliet, Dr. Ty W. Abel and Dr. Duncan MacGregor for their assistance with ascertainment and analysis of their respective cases. We thank the MUGQIC staff for assisting Pierre Lepage with the Fluidigm Access Array and next-generation sequencing. This research was made possible thanks to the support of the Lady Davis Institute/TD Bank Studentship Award, CCSRI Innovative grant to Dr. William D. Foulkes and K12 CA 090625 to Dr. Adam Esbenshade.
Conflict of interest
The authors have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is dedicated to Bernd W. Scheithauer, MD, with whom several of the co-authors have trained and/or collaborated. Bernd was a world-renowned neuropathologist with special expertise in pituitary disease. With his colleagues, Bernd described pituitary blastoma (PitB) in 2008 and he was an early participant in the work reported here. Just before his untimely death, he was thrilled to learn that several additional PitB cases had been accessioned and more so that DICER1 mutations explain PitB and its association with other childhood blastomas in this familial tumor predisposition syndrome.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
de Kock, L., Sabbaghian, N., Plourde, F. et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 128, 111–122 (2014). https://doi.org/10.1007/s00401-014-1285-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-014-1285-z